CN101355947A - 用于治疗的噻唑并嘧啶类 - Google Patents
用于治疗的噻唑并嘧啶类 Download PDFInfo
- Publication number
- CN101355947A CN101355947A CNA2006800219991A CN200680021999A CN101355947A CN 101355947 A CN101355947 A CN 101355947A CN A2006800219991 A CNA2006800219991 A CN A2006800219991A CN 200680021999 A CN200680021999 A CN 200680021999A CN 101355947 A CN101355947 A CN 101355947A
- Authority
- CN
- China
- Prior art keywords
- pain
- purposes
- chemical compound
- acid
- neuropathic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (13)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0512554.7A GB0512554D0 (en) | 2005-06-20 | 2005-06-20 | Compounds for use in therapy |
GB0512554.7 | 2005-06-20 | ||
PCT/GB2006/002248 WO2006136806A1 (en) | 2005-06-20 | 2006-06-19 | Thiazolopyrimidines for use in therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101355947A true CN101355947A (zh) | 2009-01-28 |
CN101355947B CN101355947B (zh) | 2013-06-05 |
Family
ID=34855848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006800219991A Active CN101355947B (zh) | 2005-06-20 | 2006-06-19 | 用于治疗的噻唑并嘧啶类 |
Country Status (20)
Country | Link |
---|---|
US (1) | US8349845B2 (zh) |
EP (1) | EP1896031B1 (zh) |
JP (1) | JP5055474B2 (zh) |
KR (1) | KR20080076897A (zh) |
CN (1) | CN101355947B (zh) |
AT (1) | ATE419853T1 (zh) |
AU (1) | AU2006260714B2 (zh) |
BR (1) | BRPI0614386A2 (zh) |
CA (1) | CA2612865C (zh) |
DE (1) | DE602006004735D1 (zh) |
DK (1) | DK1896031T3 (zh) |
ES (1) | ES2323981T3 (zh) |
GB (1) | GB0512554D0 (zh) |
HK (1) | HK1108842A1 (zh) |
IL (1) | IL188061A0 (zh) |
NO (1) | NO20080049L (zh) |
NZ (1) | NZ564170A (zh) |
PT (1) | PT1896031E (zh) |
WO (1) | WO2006136806A1 (zh) |
ZA (1) | ZA200711062B (zh) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5564591A (en) * | 1978-11-10 | 1980-05-15 | Teijin Ltd | Thiazolo 3, 2-a pyrimidine derivative, its preparation, and drug comprising it |
JPS5566592A (en) * | 1978-11-13 | 1980-05-20 | Teijin Ltd | 7-alkoxythiazolo 3,2-a pyrimidine derivative, its preparation, and drug containing the same |
WO1981003174A1 (en) * | 1980-04-28 | 1981-11-12 | Teijin Ltd | Thiazolo(3,2-a)pyrimidine derivatives,process for preparing same,and drug containing same |
-
2005
- 2005-06-20 GB GBGB0512554.7A patent/GB0512554D0/en not_active Ceased
-
2006
- 2006-06-19 ES ES06744265T patent/ES2323981T3/es active Active
- 2006-06-19 CN CN2006800219991A patent/CN101355947B/zh active Active
- 2006-06-19 BR BRPI0614386-5A patent/BRPI0614386A2/pt not_active Application Discontinuation
- 2006-06-19 DK DK06744265T patent/DK1896031T3/da active
- 2006-06-19 US US11/917,425 patent/US8349845B2/en active Active
- 2006-06-19 AU AU2006260714A patent/AU2006260714B2/en active Active
- 2006-06-19 JP JP2008517583A patent/JP5055474B2/ja not_active Expired - Fee Related
- 2006-06-19 PT PT06744265T patent/PT1896031E/pt unknown
- 2006-06-19 KR KR1020087001186A patent/KR20080076897A/ko not_active Application Discontinuation
- 2006-06-19 CA CA2612865A patent/CA2612865C/en active Active
- 2006-06-19 EP EP06744265A patent/EP1896031B1/en active Active
- 2006-06-19 DE DE602006004735T patent/DE602006004735D1/de not_active Expired - Fee Related
- 2006-06-19 NZ NZ564170A patent/NZ564170A/en unknown
- 2006-06-19 AT AT06744265T patent/ATE419853T1/de active
- 2006-06-19 ZA ZA200711062A patent/ZA200711062B/xx unknown
- 2006-06-19 WO PCT/GB2006/002248 patent/WO2006136806A1/en active Application Filing
-
2007
- 2007-12-11 IL IL188061A patent/IL188061A0/en unknown
-
2008
- 2008-01-04 NO NO20080049A patent/NO20080049L/no not_active Application Discontinuation
- 2008-03-17 HK HK08103060.1A patent/HK1108842A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ES2323981T3 (es) | 2009-07-28 |
JP2008543918A (ja) | 2008-12-04 |
WO2006136806A1 (en) | 2006-12-28 |
GB0512554D0 (en) | 2005-07-27 |
AU2006260714B2 (en) | 2008-11-13 |
DK1896031T3 (da) | 2009-05-11 |
NO20080049L (no) | 2008-01-17 |
CA2612865A1 (en) | 2006-12-28 |
HK1108842A1 (en) | 2008-05-23 |
EP1896031A1 (en) | 2008-03-12 |
JP5055474B2 (ja) | 2012-10-24 |
KR20080076897A (ko) | 2008-08-20 |
US20100216819A1 (en) | 2010-08-26 |
US8349845B2 (en) | 2013-01-08 |
BRPI0614386A2 (pt) | 2011-03-22 |
IL188061A0 (en) | 2011-08-01 |
CN101355947B (zh) | 2013-06-05 |
PT1896031E (pt) | 2009-04-15 |
EP1896031B1 (en) | 2009-01-07 |
AU2006260714A1 (en) | 2006-12-28 |
ZA200711062B (en) | 2010-06-30 |
ATE419853T1 (de) | 2009-01-15 |
NZ564170A (en) | 2011-03-31 |
CA2612865C (en) | 2013-03-26 |
DE602006004735D1 (de) | 2009-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6798075B2 (ja) | 神経筋障害を処置するのにおける使用のための化合物 | |
KR101536023B1 (ko) | 조합된 sert, 5-ht3 및 5-ht1a 활성을 가진 화합물의 치료 용도 | |
AU2011285928B2 (en) | Combinations of beta - 3 adrenergic receptor agonists and muscarinic receptor antagonists for treating overactive bladder | |
WO2009100380A1 (en) | Use of ranolazine for treating pain | |
US20190343817A1 (en) | Method of treating pain | |
JP3832229B2 (ja) | フェニルエテンスルホンアミド誘導体含有医薬 | |
EP3801546B1 (en) | Indole compound for treating interstitial cystitis | |
CN101355947B (zh) | 用于治疗的噻唑并嘧啶类 | |
CN101636391B (zh) | 神经病理性疼痛的预防剂和/或治疗剂 | |
CN100427089C (zh) | 吲唑衍生物用于制备治疗神经病性疼痛药物的用途 | |
JP2005314347A (ja) | 疼痛抑制剤 | |
JP4287523B2 (ja) | 抗腫瘍剤 | |
KR20110071079A (ko) | 침해 수용성 동통의 신규 치료용 의약 조성물 | |
JPS6058726B2 (ja) | プリン誘導体を有効成分として含有する抗アレルギ−,鎮痛,鎮静剤 | |
TW201206433A (en) | Association of xanthine oxidase inhibitors and calcium antagonists and use thereof | |
US20240261242A1 (en) | Methods of intravenously administering sotalol | |
US20160361286A1 (en) | 4-benzylsulfonyl-2-butenenitrile | |
EA013905B1 (ru) | Производные изоксазола, их фармацевтические композиции и способ лечения невропатической боли | |
NO750209L (zh) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: NEUROSOLUTIONS LTD. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20110217 Address after: Tokyo, Japan Applicant after: Sosei Co., Ltd. Address before: Tokyo, Japan Applicant before: Sosei Co., Ltd. Co-applicant before: Neurosolutions Limited |
|
ASS | Succession or assignment of patent right |
Owner name: BEIJING TIDE PHARMACEUTICAL CO., LTD. Effective date: 20120525 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20120525 Address after: Tokyo, Japan Applicant after: Sosei Co., Ltd. Co-applicant after: Beijing Tide Pharmaceutical Co., Ltd. Address before: Tokyo, Japan Applicant before: Sosei Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |